Jiangxi Sanxin Medtec (300453.SZ) announced its third-quarter report on October 14th. In the third quarter of 2024, the company achieved revenue of 0.396 billion yuan, a 13.69% increase from the same period last year; the net income attributable to shareholders of the listed company was 61.6669 million yuan, an 18.75% increase from the same period last year; the net income profit after deducting non-recurring gains and losses was 57.1766 million yuan, a 16.29% increase from the same period last year; with earnings per share of 0.1187 yuan.
In the first three quarters of 2024, the company achieved revenue of 1.082 billion yuan, a 16.38% year-on-year increase; the net income attributable to shareholders of the listed company was 0.168 billion yuan, an 18.74% year-on-year increase; the net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 0.152 billion yuan, an 18.84% year-on-year increase; with earnings per share of 0.3232 yuan per share.
